Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrolide resistance mechanisms in Gram-positive cocci.

J C Pechère1

  • 1Department of Microbiology and Genetics, University Medical Centre, 1 Rue Michel Servet, CH-1211, Geneva, Switzerland. pechere@cmu.unige.ch

International Journal of Antimicrobial Agents
|September 28, 2001
PubMed
Summary

Two main antibiotic resistance mechanisms exist in Gram-positive bacteria: erm genes causing high-level resistance and mefE genes enabling low-level macrolide efflux. Azithromycin effectively targets strains with mefE genes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic policies in surgery: a consensus paper.

International journal of antimicrobial agents·2005
Same author

Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.

Antimicrobial agents and chemotherapy·2004
Same author

Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy.

The Journal of antimicrobial chemotherapy·2003
Same author

Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensing.

The Japanese journal of antibiotics·2003
Same author

Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

Introduction.

International journal of antimicrobial agents·2001

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Gram-positive bacteria exhibit resistance to macrolide antibiotics through identified genetic mechanisms.
  • Two primary resistance pathways involve ribosomal RNA modification and active antibiotic efflux.

Purpose of the Study:

  • To elucidate the principal mechanisms of macrolide resistance in Gram-positive bacteria.
  • To differentiate the clinical significance and resistance levels associated with specific macrolide resistance genes.

Main Methods:

  • Analysis of genetic determinants of macrolide resistance, specifically erm and mefE genes.
  • Evaluation of bacterial protein synthesis inhibition and antibiotic efflux mechanisms.
  • Assessment of azithromycin efficacy against bacteria harboring mefE genes.

Related Experiment Videos

Main Results:

  • The erm gene confers high-level macrolide resistance by altering ribosomal RNA structure, preventing antibiotic binding.
  • The mefE gene mediates low-level macrolide resistance through an efflux mechanism.
  • Azithromycin demonstrated efficacy in eradicating mefE-carrying bacterial strains due to its concentration at infection sites.

Conclusions:

  • Erm-mediated ribosomal modification and mefE-mediated efflux are key macrolide resistance mechanisms in Gram-positive bacteria.
  • Resistance levels vary significantly between these two mechanisms.
  • Azithromycin holds therapeutic potential against specific macrolide-resistant bacterial infections.